Limitations aid prevention
CLABSI prevention begins with limiting central access line use to established indications. When central lines are indicated, checklists and bundles can help ensure proper insertion. The next article in this series will focus on access line maintenance and what to do if a CLABSI occurs.
Michelle DeVries is senior infection control officer for Methodist Hospitals in Gary, Indiana, and is an adjunct research fellow at Griffith University in Australia. She serves on the speakers bureau for Access Scientific, Becton Dickinson, Ethicon, and Eloquest.
Selected references
Blanco-Mavillard I, Rodríguez-Calero MA, Castro-Sánchez E, Bennasar-Veny M, De Pedro-Gómez J. Appraising the quality standard underpinning international clinical practice guidelines for the selection and care of vascular access devices: A systematic review of reviews. BMJ Open. 2018;8(10):e021040.
Bozaan D, Skicki D, Brancaccio A, et al. Less lumens-less risk: A pilot intervention to increase the use of single-lumen peripherally inserted central catheters. J Hosp Med. 2019;14(1):42-6.
Centers for Disease Control and Prevention. Healthcare-associated infections: Current HAI progress report. March 19, 2019. cdc.gov/hai/data/portal/progress-report.html
Cheng HY, Lu CY, Huang LM, Lee PI, Chen JM, Chang LY. Increased frequency of peripheral venipunctures raises the risk of central-line associated bloodstream infection in neonates with peripherally inserted central venous catheters. J Microbiol Immunol Infect. 2016;49(2):230-6.
Chopra V, Flanders SA, Saint S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(suppl 6):S1-40.
Gorski L, Hadaway L, Hagle ME, McGoldrick M, Orr M, Doellman D. Infusion therapy standards of practice. J Infus Nurs. 2016;39(suppl 1):S1-159.
Kornbau C, Lee KC, Hughes GD, Firstenberg MS. Central line complications. Int J Crit Illn Inj Sci. 2015;5(3):170-8.
Laan BJ, Spijkerman IJ, Godfried MH, et al. De-implementation strategy to reduce the inappropriate use of urinary and intravenous CATheters: Study protocol for the RICAT-study. BMC Infect Dis. 2017;17(1):53.
Marschall J, Mermel LA, Fakih M, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753-71.
Moureau N, Sigl G, Hill M. How to establish an effective midline program: A case study of 2 hospitals. J Assoc Vasc Access. 2015;20(3):179-88.
O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93.
Pathak R, Gangina S, Jairam F, Hinton K. A vascular access and midlines program can decrease hospital-acquired central line-associated bloodstream infections and cost to a community-based hospital. Ther Clin Risk Manag. 2018;14:1453-6.
Pathak R, Patel A, Enuh H, Adekunle O, Shrisgantharajah V, Diaz K. The incidence of central line-associated bacteremia after the introduction of midline catheters in a ventilator unit population. Infect Dis Clin Pract (Baltim Md). 2015;23(3):131-4.
Pittiruti M, Scoppettuolo G, Dolcetti L, et al. Clinical experience of a subcutaneously anchored sutureless system for securing central venous catheters. Br J Nurs. 2019;28(2):S4-14.
Quan KA, Cousins SM, Porter DD, et al. Electronic health record solutions to reduce central line-associated bloodstream infections by enhancing documentation of central line insertion practices, line days, and daily line necessity. Am J Infect Control. 2016;44(4):438-43.
Ratz D, Hofer T, Flanders SA, Saint S, Chopra V. Limiting the number of lumens in peripherally inserted central catheters to improve outcomes and reduce cost: A simulation study. Infect Control Hosp Epidemiol. 2016;37(7):811-7.
Rupp ME, Karnatak R. Intravascular catheter-related bloodstream infections. Infect Dis Clin North Am. 2018;32(4):765-87.
Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-46.
ant5-INFECTION CLABSI-418